UNICO-GRECO cardio-oncology program
@unico_greco
Unité de cardio-oncologie /
Groupe de recherche clinique/ congrès de cardio oncologie, juin 2023, PARIS/
S EDERHY / C FRERE/JE SALEM
ID: 1166093208251719680
26-08-2019 21:01:13
344 Tweet
231 Followers
203 Following
📢 Emeline COLOMBA et Stephane EDERHY abordent ensemble les toxicités de l'association immunothérapie et traitement anti-angiogénique. 💊💔 Points clés : 1️⃣ Identifier les patients à haut risque CV 2️⃣ Stratégie de surveillance cardio-online.fr/Videos/Les-Ent… #Cardioonco
Was so nice to host today UNICO-GRECO cardio-oncology program (in my desk) the SupAR hero Salim S. Hayek, MD and Lauren A. Baldassarre, MD, FACC, FSCCT, FSCMR to foster collab in the cardio-onc space ! Paris is hot this summer - feel free to visit ! Javid Moslehi
We began EMPACT study- 🇵🇱Polish phase 3 randomized trial, double-blind, placebo-controlled to evaluate efficacy and safety of empagliflozin in the prevention of cardiotoxicity in cancer patients treated with anthracyclines 🔥 support from Agencja Badań Medycznych leader Narodowy Instytut Onkologii, Warszawa
In adult cancer patients, nonadherence to antihypertensive medication was common and was associated with worse outcomes. #AHAJournals Mi-Hyang Jung ahajrnls.org/3rNaAkF
📽️ Envie de tout savoir sur les thérapies ciblées en #Cardioonco ? Ne manquez pas cette vidéo de Mariana Mirabel et Pierre-Yves Courand et découvrez les meilleures pratiques pour gérer l'#HTA chez ces patients ! Regardez dès maintenant👉ow.ly/rHFg50PfTqc Pierre-Yves COURAND
🎥 Comment gérer une patiente avec dysfonction VG avant un traitement du cancer du sein ? Jennifer Cautela et François Deharo expliquent les étapes clés basées sur les recommandations ESC 2022 de #Cardioonco ! Regardez dès maintenant👉ow.ly/cSmI50PfUny Jennifer Cautela
Happy to share our latest study on PT-Cy! Reducing PT-Cy total dose to 70 mg/kg is associated with ✅Earlier hematopoietic recovery ✅Lower incidences of bacteremia, hemorrhagic cystitis & cardiac events ✅Higher GRFS READ MORE 👉 rdcu.be/djOUS Cc Mohamad Mohty #bmtsm
This case demonstrates the limitations of imaging alone to accurately distinguish between benign and malignant tumors and highlights the contribution histopathology provides to reach an accurate diagnosis. Read our CV Case Journal article here: bit.ly/3P93jVg #echofirst
#ESCCongress Emanuele Di Angelantonio presents the SCORE2- #diabetes risk score: 💚estimates 10-year #CVD events in type2 #diabetes pts 💚calibrated to predict the risk in low, moderate, high & very high risk countries 💚separate risk for 🚹 &🚺 There is also a APP‼️ European Society of Cardiology
Starting Nov 2023, we're hiring an instructor of medecine (french speaking) to expand our team dedicated to clinical research in cardio-oncology, cardio-metabolism, endocrinology, nutrition and immunology in Hôpital Pitié-Salpêtrière AP-HP clinical investigation center (Paris). MP if interested !
Excited to share this fantastic collaboration w/ Lavine Lab! Great lead work by Pan Ma & Juan Qin, PhD! Out in Circulation today. Immune checkpoint inhibitor (ICI)-myocarditis is characterized by lots of macrophages & lymphocytes in the heart. ahajournals.org/doi/abs/10.116…
DPC de cardio-oncologie : Les fondamentaux , 23/11/ 2023 de 16h à 19h, présentiel, congrès du CNCH, animé par notre experte le Dr BAUDET Inscription : Praticiens libéraux : mondpc.fr (action 35522325013) PH/salariés : contacter [email protected]
Great to see Cardiac CARE Trial in print. Does high sensitivity troponin identify anthracycline treated patients who benefit from neurohormonal blockade?Grateful to trial participants and fantastic Cardiac CARE collaborators.#Cardioonc Ninian Lang Nicholas Mills International Cardio-Oncology Society